Is the targeted drug venetoclax/venetoclax available in India?

Venetoclax/Venetoclax is a targeted drug mainly used to treat adult chronic lymphocytic leukemia or small lymphocytic leukemia. In some cases, it may also be used in combination with other drugs to treat acute myeloid leukemia in adults 75 years of age or older or who are unable to use standard chemotherapy because of other medical conditions.

However, it is understood that there is currently no Indian version of the original drug or generic version of Venetekla, and there may be original drugs for sale in India. The original drug of Venacla has been marketed and sold in many regions, including China, the United States, the European Union and other places. Its generic drugs are also produced and marketed overseas. Its drug ingredients are basically the same as those of the original drug, but there may be some differences in price.

Veneclase inhibits BCL-2 protein, a protein that regulates cell death, including promoting or inhibiting apoptosis. In some cancers, such as chronic lymphocytic leukemia and acute myeloid leukemia, the BCL-2 protein is overexpressed on the surface of cancer cells. This overexpression allows tumor cells to survive longer and may lead to resistance to chemotherapy. Laboratory studies have shown that venetoclax can bind to this protein and inhibit the cancerous process of lymphocytes in chronic lymphocytic leukemia and acute myeloid leukemia.

It is worth noting that there are some side effects that may occur during use of venetoclax, some of which are relatively common. These side effects are usually temporary and may last from a few days to a few weeks. These side effects may have a negative impact on the patient's physical health, so it is necessary to pay close attention and seek medical guidance and treatment when necessary.